Grufity logoGrufity logo

STE

184.68USD+1.11(+0.60%)Delayedas of 07 Dec 2022, 10:16 am

STERIS plc

Market Summary

USD184.68+1.11Delayedas of 07 Dec 2022, 10:16 am
0.60%

STE Alerts

STE Stock Price

RSI Chart

Valuation

Market Cap

17.3B

Price/Earnings

45.87

Price/Sales

3.62

Price/Cashflow

21.11

MarketCap/EBT

36.14

Price/Sales

Profitability

Operating Margin

46.10%

EBT Margin

10.02%

Return on Equity

5.88%

Return on Assets

3.37%

Fundamentals

Revenue

Revenue (TTM)

4.8B

Revenue Y/Y

0.3%

Revenue Q/Q

3.81%

Earnings

Earnings (TTM)

-8.1M

Earnings Y/Y

-551.63%

Earnings Q/Q

-383.37%

Price Action

52 Week Range

158.76254.11
(Low)(High)

Last 7 days

2.9%

Last 30 days

13.0%

Last 90 days

-9.7%

Trailing 12 Months

-17.8%

Financial Health

Current Ratio

2.03

Debt/Equity

0.46

Debt/Cashflow

0.28

Investor Care

Dividend Yield

0.99%

Dividend/Share (TTM)

1.76

Buy Backs (1Y)

0.20%

Diluted EPS (TTM)

-0.11

Peers (Alternatives to STERIS)

View All Peers In Detail
NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
10.2T
429.9M
-15.19% 31.17%
185.5K
28.0K
144.70% 331.94%
115.4B
30.8B
-8.94% -28.67%
22.17
3.71
-3.11% -8.14%
86.7B
17.9B
11.64% -6.61%
41.71
4.92
7.67% 29.32%
86.3B
6.1B
11.18% -17.75%
62.6
14.1
11.47% -18.42%
67.1B
18.9B
10.66% 2.81%
38.21
3.25
-6.81% -14.96%
43.9B
5.4B
5.44% -35.45%
30.09
8.18
5.29% -1.25%
MID-CAP
6.7B
998.4M
9.55% 2.62%
44.21
6.87
6.04% -19.01%
6.4B
806.4M
33.31% -13.25%
-331.15
7.96
20.10% -221.96%
3.9B
380.1M
-6.98% -2.00%
-29.57
10.69
18.85% -63.58%
3.6B
790.7M
14.84% -68.69%
-273.58
4.7
19.65% -412.22%
SMALL-CAP
1.6B
126.8M
23.76% 23.16%
-26.38
14.01
34.44% -10.05%
1.0B
795.9M
15.03% -14.89%
-131.34
1.33
8.11% 182.50%
994.0M
154.8M
3.15% -46.03%
-10.57
6.72
60.29% -2309.58%
606.7M
236.2M
-5.60% -30.91%
-16.43
2.57
-8.79% -175.19%

Financials for STERIS

Income Statement (Last 12 Months)
(In Millions)
Description(%) Q/Q2022Q32022Q22022Q12021Q42021Q3
Revenue0.1%4,7774,7734,5854,2483,848
Gross Profit2.5%2,1602,1082,0161,8251,632
Operating Expenses30.9%2,0131,5381,5911,3471,210
  S&GA Expenses-1.5%1,4221,4441,5031,2701,142
  R&D Expenses6.5%10195887971
Earnings Before Taxes-88.3%56478315381338
Net Income-102.2%-8.14377244279250
Balance Sheet
(In Millions)
Description(%) Q/Q2022Q32022Q22022Q12021Q42021Q3
Assets-6.2%10,49011,18811,42411,69011,752
  Current Assets2.2%1,8881,8481,8791,9271,905
    Cash Equivalents-18.4%258316348359383
  Inventory4.0%645620575595565
  Net PPE-0.1%1,5721,5731,5531,5221,511
  Goodwill-14.3%3,7054,3214,4045,1155,133
Liabilities-1.9%4,6764,7694,8795,0665,208
  Current Liabilities-3.9%873908922904786
.    Short Term Borrowings0%15115114312822
  Long Term Debt-2,945----
    LT Debt, Non Current1.0%2,8742,8462,9453,1753,422
Shareholder's Equity-9.4%5,8026,4086,5326,6116,536
  Retained Earnings-17.6%1,6952,0571,9991,9901,893
Shares Outstanding-0.2%100100100100100
Minority Interest-1.6%111212129
Float-20,355----
* denotes actual numbers (not divided by Millions)
Cashflow (Last 12 Months)
(In Millions)
Description(%) Q/Q2022Q32022Q22022Q12021Q42021Q3
Cashflow From Operations-8.2%752819685701662
  Share Based Compensation0.6%4040585450
Cashflow From Investing-12.2%-193.57-172.44-666.56-878.39-1,721.63
Cashflow From Financing23.0%-650.23-844.391162941,125
  Dividend Payments2.3%176172163154145
  Buy Backs44.7%10170562825

Risks

What is the probability of a big loss on STE?

29.2%


Probability that STERIS stock will be more than 20% underwater in next one year

23.1%


Probability that STERIS stock will be more than 30% underwater in next one year.

0%


Probability that STERIS stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does STE drawdown profile look like?

Y-axis is the maximum loss one would have experienced if STERIS was unfortunately bought at previous high price.

Returns

Cumulative Returns on STE

19.7%


10-Year Cumulative Returns

15.4%


7-Year Cumulative Returns

16.8%


5-Year Cumulative Returns

6.9%


3-Year Cumulative Returns

What are the long-term rolling returns for STE?

FIve years rolling returns for STERIS.

Which funds bought or sold STE recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
2022-11-23
Toroso Investments, LLC
ADDED
4.85
-80,000
438,000
0.02%
2022-11-23
Eagle Bay Advisors LLC
ADDED
17.39
-741
4,000
-%
2022-11-22
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY
NEW
-
1,514,000
1,514,000
0.02%
2022-11-22
B. Riley Wealth Advisors, Inc.
NEW
-
221,000
221,000
0.01%
2022-11-22
CVA Family Office, LLC
-
-
-39,000
4,000
-%
2022-11-21
DEARBORN PARTNERS LLC
-
-
-7,058,000
29,566,000
1.30%
2022-11-21
FourThought Financial, LLC
-
-
12,000
37,000
-%
2022-11-21
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
-
-
-5,667,000
27,422,000
0.05%
2022-11-17
CENTRAL TRUST Co
REDUCED
-21.13
-435,000
761,000
0.03%
2022-11-17
M&T Bank Corp
-
-
-51,000
7,965,000
0.04%

1–10 of 46

Latest Funds Activity

Are funds buying STE calls or puts?
Are funds bullish or bearish(Calls - Puts)?
No. of funds that own STE

STERIS News

Simply Wall St

Have STERIS plc (NYSE:STE) Insiders Been Selling Their Stock?.5 hours ago

Midland Daily News

STE Fair Value

Recent SEC filings of STERIS

View All Filings
Date Filed Form Type Document
Nov 09, 2022
8-K
Current Report
Nov 09, 2022
10-Q
Quarterly Report
Oct 12, 2022
4
Insider Trading
Oct 11, 2022
4
Insider Trading
Oct 05, 2022
4
Insider Trading
Oct 05, 2022
4
Insider Trading
Oct 05, 2022
4
Insider Trading
Oct 05, 2022
4
Insider Trading
Oct 05, 2022
4
Insider Trading

Latest Insider Trading transactions for STE

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
2022-10-10
Xilas Andrew
ACQUIRED
-
-
503
SVP and GM, Dental
2022-10-10
Xilas Andrew
SOLD FOR TAXES
-25,115.4
168.56
-149
SVP and GM, Dental
2022-10-07
Xilas Andrew
ACQUIRED
-
-
606
SVP and GM, Dental
2022-10-07
Xilas Andrew
SOLD FOR TAXES
-30,464
170.19
-179
SVP and GM, Dental
2022-06-15
Zangerle John Adam
SOLD
-545,919
205.31
-2,659
Sr. VP, Gen Counsel, and Sec.
2022-06-02
TOKICH MICHAEL J
ACQUIRED
-
-
2,256
Sr. Vice Pres., CFO
2022-06-02
Carestio Daniel A
ACQUIRED
-
-
9,476
President and CEO
2022-06-02
Madsen Julia
SOLD (Taxes)
-28,415
227.32
-125
Senior VP, Life Sciences
2022-06-02
Madsen Julia
ACQUIRED
-
-
1,408
Senior VP, Life Sciences
2022-06-02
Fraser Mary Clare
ACQUIRED
-
-
2,028
SVP & Chief HRO

1–10 of 50

Daniel A. Carestio
13000
STERIS plc provides infection prevention and other procedural products and services worldwide. It operates in three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. This segment offers its products and services to acute care hospitals and other healthcare settings. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier and sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The company was founded in 1985 and is based in Dublin, Ireland.

STE Income Statement

2022-09-30
CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited) - USD ($)
$ in Thousands
3 Months Ended6 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Revenues:    
Revenues$ 1,200,517$ 1,196,985$ 2,357,008$ 2,165,407
Fair value adjustment related to convertible debt liability04,883027,806
Cost of revenues:    
Total cost of revenues668,182716,6411,306,8751,258,781
Gross Profit532,335480,3441,050,133906,626
Operating expenses:    
Selling, general, and administrative323,195344,799657,821738,551
2591744000490,5650490,5650
Research and development24,92818,83249,67937,024
Restructuring Costs6221088224
Total operating expenses838,750363,8411,198,153775,799
Income from operations(306,415)116,503(148,020)130,827
Non-operating expenses, net:    
Interest expense26,12323,03648,79744,848
Interest income and miscellaneous expense524(1,023)1,294(2,457)
Total non-operating expenses, net26,64726,89650,09170,197
Income before income tax expense(333,062)89,607(198,111)60,630
Income tax expense(17,831)19,9826,36512,907
Net Income(315,231)69,625(204,476)47,723
Less: Net Income Attributable to Noncontrolling Interest54(186)(453)(281)
Net income (loss) attributable to shareholders$ (315,285)$ 69,811$ (204,023)$ 48,004
Net income per common share [Abstract]    
Basic$ (3.15)$ 0.70$ (2.04)$ 0.51
Diluted(3.15)0.69(2.04)0.50
Cash dividends declared per common share outstanding$ 0.47$ 0.43$ 0.90$ 0.83
Product [Member]    
Revenues:    
Revenues$ 666,394$ 685,238$ 1,303,470$ 1,174,517
Cost of revenues:    
Cost of Goods and Services Sold351,079427,484683,934698,890
Service [Member]    
Revenues:    
Revenues534,123511,7471,053,538990,890
Cost of revenues:    
Cost of Goods and Services Sold$ 317,103$ 289,157$ 622,941$ 559,891

STE Balance Sheet

2022-09-30
CONSOLIDATED BALANCE SHEETS (unaudited) - USD ($)
$ in Thousands
Sep. 30, 2022
Mar. 31, 2022
Current assets:  
Cash and cash equivalents$ 258,259$ 348,320
Accounts receivable (net of allowances of $22,196 and $24,371 respectively)780,113799,041
Inventories, net644,936574,999
Prepaid expenses and other current assets204,991156,637
Total current assets1,888,2991,878,997
Property, plant, and equipment, net1,572,3981,552,576
Operating Lease, Right-of-Use Asset174,073188,480
Goodwill3,705,1404,404,343
Intangible Assets, Net (Excluding Goodwill)3,077,4923,328,537
Other assets72,23470,661
Total assets10,489,63611,423,594
Current liabilities:  
Accounts payable233,308225,737
Accrued income taxes16,66126,873
Accrued payroll and other related liabilities133,839183,721
Capital Lease Obligations, Current33,96836,472
Short-term Debt151,000142,875
Accrued expenses and other304,039306,544
Total current liabilities872,815922,222
Long-term indebtedness2,873,9362,945,481
Deferred Income Taxes and Other Tax Liabilities, Noncurrent710,087780,619
Capital Lease Obligations, Noncurrent143,451155,056
Other Liabilities, Noncurrent75,90075,579
Total liabilities4,676,1894,878,957
Commitments and contingencies (see Note 8)
Common shares, with $0.001 par value; 500,000 authorized; 99,868 shares issued; and 100,067 shares outstanding4,705,1184,742,920
Retained earnings1,695,0871,999,244
Accumulated other comprehensive income(598,148)(209,808)
Total shareholders' equity5,802,0576,532,356
Noncontrolling interest11,39012,281
Total equity5,813,4476,544,637
Total liabilities and equity$ 10,489,636$ 11,423,594